Hook & thesis
Would Warren Buffett buy Berkshire Hathaway Class B at $487.50 today? You can make a reasonable case that the stock is attractively priced for a disciplined buyer. The company still generates substantial free cash flow ($19.33B last reported), trades at a modest price-to-earnings of ~15.7 and a price-to-book near 1.5, and sits on a near-record cash reserve of $373.3B. Those facts alone give management significant optionality to repurchase shares, make large strategic purchases or withstand cyclical shocks.
My trade idea: take a long position in BRK.B with a clear stop and target, sized to your risk tolerance. This is a long-term (46-180 trading days) position - specifically I prefer a 180 trading day horizon - that bets on capital deployment under CEO Greg Abel, stabilization of insurance results, and incremental upside as some impairments fade and earnings normalize.
What Berkshire actually is and why the market should care
Berkshire Hathaway is a highly diversified holding company operating across insurance (including GEICO and Berkshire Hathaway Reinsurance), freight rail (BNSF), utilities and energy (BHE), manufacturing, wholesale distribution (McLane), and retail/services. The business mixes predictable, regulated cash flows (BHE, BNSF) with episodic, high‑margin insurance and investment income. That blend is why Berkshire has historically outperformed broad benchmarks: capital allocation choices shape returns more than near-term sales swings.
The market cares because Berkshire is both a proxy for long-term capital allocation and a giant source of deployable capital. Management reported a near-record cash reserve of $373.3B in Q4 2025 while posting $19.33B in free cash flow in the latest period. Even after a $4.5B impairment charge in Q4 2025, the company retains the scale to buy assets on attractive terms or repurchase stock at prices that could generate meaningful value over a couple of years.
Supporting numbers
- Current price: $487.507 (last reported).
- Market capitalization: ~$1.05T.
- P/E: ~15.7; EPS: $31.27.
- P/B: ~1.51.
- Free cash flow (most recent): $19.326B.
- Return on equity: 9.66%; debt-to-equity: 0.18.
- 52-week range: $455.19 - $542.07.
- Near-record cash reserve reported in Q4 2025: $373.3B; Q4 also included a $4.5B impairment.
Valuation framing
At roughly $487.50 per Class B share, Berkshire trades at single-digit to mid‑teens multiples by several measures: P/E ~15.7 and P/B ~1.5. For a conglomerate that controls both stable regulated businesses and cyclical insurance/investment results, those multiples look reasonable. Enterprise value sits near $1.1026T with EV/EBITDA around 24.5, reflecting the large investment base and earnings profile. The stock sits well below its 52-week high of $542.07 but above the 52-week low of $455.19, a band the company has traded within recently as the market digested leadership change and portfolio moves.
Two valuation angles to keep in mind:
- Absolute: P/E in the mid‑teens with positive free cash flow and almost zero net balance-sheet stress (debt/equity ~0.18) is conservative for a company with a $373B strategic cash cushion.
- Optionality: the large cash reserve means management can opportunistically deploy capital into high-return assets or expand buybacks; that optionality is not fully captured by static multiples and can justify a premium if execution is convincing.
Catalysts (what could push the shares higher)
- Capital deployment by the new CEO, Greg Abel, into high-return purchases rather than sitting on cash; the market often rewards visible, value-accretive deals.
- Improvement in insurance underwriting margins and fewer large impairments, reversing the $4.5B Q4 2025 hit.
- Higher commodity or equity market returns that lift Berkshire’s investment income and realized gains (the company increased its energy holdings in late 2025).
- Share repurchases or meaningful buyback program announcements funded from the $373.3B cash reserve.
- Operational improvements at BNSF and BHE that generate steady cash flow and raise investor confidence.
Trade plan (actionable)
This is a long-biased trade sized for patient value investors. I recommend:
| Action | Price | Horizon |
|---|---|---|
| Entry | $487.50 | Long term (180 trading days) |
| Target | $540.00 | |
| Stop loss | $455.19 |
Rationale: Entry near $487.50 captures the current market price, target $540.00 is near the 52-week high and reflects a re-rating if capital deployment and earnings recover, and the stop at $455.19 is set at the recent 52-week low—an objective technical level that also reflects downside where investors likely reassess the thesis. Plan duration: long term (180 trading days) to allow capital allocation outcomes and insurance cycles to play out.
Technicals & positioning
The stock shows mild bearish momentum on short-term indicators: 10–50 day SMAs and EMAs are slightly above current levels and the MACD histogram reads negative. RSI sits around 44.8, indicating the stock is not oversold but has room to move lower on bad news. Short interest and short-volume metrics imply modest bearish positioning: days-to-cover runs near ~2 days in recent settlements, and daily short volume has been a meaningful portion of total volume on several recent sessions. Use the stop strictly; the technical picture argues for patience rather than aggressive averaging down.
Risks and counterarguments
No investment is without downside. Key risks to this long idea include:
- Insurance volatility and further impairments. Q4 2025 included a $4.5B impairment; a repeat or larger charge could materially reduce book value and earnings.
- Cash underutilization. Management may keep the $373.3B reserve idle or make poor acquisitions that destroy value instead of returning capital to shareholders.
- Regulatory or macro shocks. A severe recession, an extended low-yield environment, or regulatory headwinds for the utilities or rail businesses could compress margins across segments.
- Leadership transition execution risk. Warren Buffett stepped down and Greg Abel is now CEO. Even if Abel adheres to Buffett’s discipline, the market may punish missteps or a change in capital allocation philosophy.
- Sector weakness. Financials and insurance/transportation sectors are under pressure at times; a sector–specific drawdown could pressure the conglomerate despite fundamentals.
Counterargument: The main counter to the buy thesis is that cheap multiples reflect secular challenges and not just a cyclical trough. If insurance margins structurally worsen or capital is repeatedly deployed into low-return assets, the stock could trade below current book multiples for an extended period. That outcome would make this a poor multi-quarter trade.
What would change my mind
I would become more bullish if management announces an explicit, sizable buyback program or completes a high-quality acquisition that meaningfully increases recurring cash flow. Conversely, I would reconsider the trade if Berkshire takes on materially more leverage, reports another large impairment cycle exceeding the Q4 2025 charge, or if capital is allocated into assets with returns below the company’s cost of equity.
Conclusion
Berkshire Hathaway at $487.50 is an attractive, pragmatic long for investors willing to give management time to deploy capital and for insurance cycles to normalize. The valuation is reasonable on multiple metrics, the balance sheet is strong (debt/equity ~0.18) and the cash reserve provides meaningful optionality. For disciplined investors comfortable with conglomerate complexity and the risks listed above, the trade plan with entry $487.50, target $540.00 and stop $455.19 over a 180 trading day horizon provides a clear, rule-based way to participate.
Key monitoring checklist
- Watch quarterly results for underwriting gains/losses and any new impairment charges.
- Monitor announcements about capital deployment - buybacks, large equity or asset purchases.
- Track BNSF and BHE operating trends and free cash flow generation.
- Pay attention to macro shocks that affect insurance losses or freight/energy demand.
Trade idea: Long BRK.B at $487.50, target $540.00, stop $455.19; horizon: long term (180 trading days); risk level: medium.